SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Aspira Pathlab & Diagnostics L

BSE: 540788 22 Aug 2025
Healthcare
₹ 58.6
Aspira Pathlab & Diagnostics Limited specializes in Healthcare Service Provider within the Healthcare sector.

Aspira Pathlab & Diagnostics L - Share Price & Details

Market Cap
₹61.2
High /Low
107.0 / 30.0
Stock P/E
23.9
Book Value
₹11.9
Dividend Yield
0.0
ROCE
17.2
ROE
₹23.8
Face Value
10.0
PEG Ratio
-1.06
EVEBITDA
₹14.2
Debt
3.20
CMP / FCF
78.2
Debt to equity
₹0.26
NP Ann
2.07
High price all time
124.0
Piotroski score
₹8.0
Graham Number
25.8
No. Eq. Shares
1.03
Net CF
₹0.95
Net profit
2.56
Price to book value
5.01
Interest Coverage
₹8.26
Low price all time
14.2
Industry PE
40.5
Reserves
₹1.92
Free Cash Flow
₹1.71

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
Aspira Pathlab & Diagnostics L59.077.2357.770.7061.223.9
VASUNDHARA RASAYANS LTDNANANANA59.815.2
TRANSCHEM LTD.39.867.3024.240.6057.512.6

Peer Comparison Chart


About Aspira Pathlab & Diagnostics L

Aspira Pathlab & Diagnostics Limited, with Security Code 540788, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Aspira Pathlab Reports Strong Financial Growth and Operational Achievements in June 2025

(13 Aug 2025)
Aspira Pathlab & Diagnostics has announced its financial results for the quarter ending June 2025, showcasing significant growth.
Read more →

aspira pathlab and diagnostics to convene board meeting

(06 Aug 2025)
Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 12 August 2025.
Read more →

Aspira Pathlab Reports Strong Sales Growth Amid Positive Market Sentiment Shift

(06 Aug 2025)
Aspira Pathlab & Diagnostics has experienced a recent evaluation adjustment, indicating a shift in market sentiment.
Read more →

Top Healthcare Stocks in India Stocks Set To Rise - Free Capital Allocation Plans

(30 Jul 2025)
【Market Focus】✌️ Our research team monitors institutional buying trends and insider transactions to identify stocks primed for 200%+ gains,...
Read more →

Is Can Fin Homes Limited (CANFINHOME) a Good Long Term Bet - Massive stock growth

(24 Jul 2025)
【Stock Buzz】✌️ Join thousands of investors who have doubled or tripled their capital by following our real-time trade alerts and...
Read more →

Is ROST a good long term investment - Consistent wealth multiplication

(23 Jul 2025)
【Stock Analysis】✌️ Take advantage of expert market timing and detailed analysis to discover stocks ready for explosive 200%+ growth.
Read more →

Company Updates